GLYCEROLYTE 57 SOLUTION
GLYCEROLYTE 57 SOLUTION
Approved
DIN Number
00783668
Drug Class
Human
Market Date
Dec 31, 1991
Company
HC
Fresenius Kabi AG
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number00783668
AIG Number0520437001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V07AC BLOOD TRANSFUSION, AUXILIARY PRODUCTS
Product Specifications
Dosage FormSolution
Route of Administration0-Unassigned
AHFS Classification92:92.00
Health Canada Classification
ACTIVE INGREDIENTS (5)
GLYCERINEActive
Strength: 57 G / 100 ML
Monograph: GLYCERINE
POTASSIUM CHLORIDEActive
Strength: 30 MG / 100 ML
Monograph: POTASSIUM CHLORIDE
SODIUM LACTATEActive
Strength: 1.6 G / 100 ML
Monograph: SODIUM LACTATE
SODIUM PHOSPHATE DIBASICActive
Strength: 124.2 MG / 100 ML
Monograph: SODIUM PHOSPHATE DIBASIC
SODIUM PHOSPHATE MONOBASICActive
Strength: 51.7 MG / 100 ML
Monograph: SODIUM PHOSPHATE MONOBASIC